DAVID P. LUCI - 03 Jan 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ David P. Luci
Issuer symbol
ACXP
Transactions as of
03 Jan 2024
Transactions value $
$70,066
Form type
4
Filing time
04 Jan 2024, 16:24:50 UTC
Previous filing
24 Feb 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Options Exercise $70,066 +19,737 +1.9% $3.55 1,048,197 03 Jan 2024 Direct
holding ACXP Common Stock 15,083 03 Jan 2024 By spouse
holding ACXP Common Stock 35,000 03 Jan 2024 By child

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Options Exercise $0 -19,737 -100% $0* 0 03 Jan 2024 Common Stock 19,737 $3.55 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.